Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.
Cell Line Description:
HCC2218 BL is a B lymphoblastoid cell line initiated from peripheral blood lymphocytes from the same patient as HCC2218 by transformation with Epstein-Barr virus (EBV). HCC2218 was derived from a female whose family members included several members with cancer; four lung cancer patients (two of them, non-smokers), two breast cancer patients (one of them also had lung cancer) and one colon cancer patient. DNA isolated from HCC2218, a breast ductal carcinoma cell line, is available as ATCC CRL-2343D.
